Ivim Health GLP-1 ID at a Glance (2026) Program Type: Telehealth GLP-1 weight management (virtual consultations + medication delivery) Medication: Primarily compounded semaglutide and compounded tirzepatide (not FDA-approved finished products) Published Study: 1,131 completers, 19.5% average body weight reduction at 52 weeks (retrospective, company-authored, no control group) Starting Cost: Approximately $75-$133/month medication + $74.99/month program fee (verify current pricing on official website) Cancellation Policy: No cancellation once program term begins (1, 2, 4, or 6 months) Prescription Required: Yes - clinical eligibility determined solely by a licensed clinician after medical evaluation Coverage: 49 U.S
Compounded medications are not FDA-approved but are regulated by state pharmacy boards and the DEA
The supplier company is located in Hangzhou, Zhejiang, and is one of the leading sellers of listed products
All protocols were approved by the Institutional Animal Care Committee at the University of British Columbia and conformed to the guidelines set out by the Canadian Counsel on Animal Care
By strategically combining the power of a GLP-1 agonist with the energy-producing properties of B12, this compounded drug aims to enhance your results and improve how you feel
We never use compounded drugs, which often come with unverified potency and safety concerns
